APA (7th ed.) Citation

E, A., A, B., S, U., G, G., RE, B., R, K., . . . G, G. (2023). Outcomes of patients with therapy-related myeloid neoplasms after treatment with poly(ADP-ribose) polymerase proteins inhibitors for solid tumours. British journal of haematology, 201(3), e25. https://doi.org/10.1111/bjh.18766

Chicago Style (17th ed.) Citation

E, Almanza-Huante, et al. "Outcomes of Patients with Therapy-related Myeloid Neoplasms After Treatment with Poly(ADP-ribose) Polymerase Proteins Inhibitors for Solid Tumours." British Journal of Haematology 201, no. 3 (2023): e25. https://doi.org/10.1111/bjh.18766.

MLA (9th ed.) Citation

E, Almanza-Huante, et al. "Outcomes of Patients with Therapy-related Myeloid Neoplasms After Treatment with Poly(ADP-ribose) Polymerase Proteins Inhibitors for Solid Tumours." British Journal of Haematology, vol. 201, no. 3, 2023, p. e25, https://doi.org/10.1111/bjh.18766.